Traditional and Complementary Medicine Use among Cancer Patients in Asian Countries: A Systematic Review and Meta-Analysis
Verwendung traditioneller und komplementärer Medizin bei Krebspatient:innen in asiatischen Ländern: systematische Übersicht und Metaanalyse
Cancers · 11.09.2024 · 16 (18) · 3130
DOI: 10.3390/cancers16183130 ↗Auf einen Blick
In 41 Studien aus 14 asiatischen Ländern nutzten 49,3 % der Krebspatient:innen T&CM. Die Offenlegungsrate gegenüber Ärzt:innen lag bei 38,2 %.
Fragestellung
Wie häufig nutzen Krebspatient:innen in Asien traditionelle und komplementäre Medizin, und wie oft wird dies offengelegt?
Methode
Systematische Suche in PubMed, EMBASE, Web of Science und CINAHAL bis Januar 2023; 41 Studien; Random-Effects-Modell; Qualitätsbewertung mit AXIS.
Ergebnisse
41 geeignete Studien mit 14.976 Teilnehmenden. Prävalenz der T&CM-Nutzung: 49,3 % (24,0 % bis 94,8 %); Offenlegungsrate: 38,2 % (11,9 % bis 82,5 %). Frauen nutzten T&CM um 22,0 % häufiger als Männer.
Einschränkungen
Einflussfaktoren auf die Offenlegung waren unzureichend untersucht.
Schlussfolgerung der Autor:innen
Die Offenlegungsrate von T&CM bei Ärzt:innen bleibt niedrig; zukünftige Forschung soll die Determinanten der Nichtoffenlegung identifizieren.
Kernaussagen
- T&CM-Nutzung bei 49,3 % der Krebspatient:innen
- Offenlegung gegenüber Ärzt:innen nur 38,2 %
- Frauen nutzten T&CM häufiger als Männer
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 11.09.2024. Verfasst von Soojeung Choi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Global Health and Development, Graduate School, Hanyang University, Seoul 04763, Republic of Korea. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Globally, cancer patients frequently use T&CM during their treatment for various reasons. The primary concerns regarding the use of T&CM among cancer patients are the potential risks associated with interactions between pharmaceuticals and T&CM, as well as the risk of noncompliance with conventional cancer treatments. Despite the higher prevalence of T&CM use in Asia, driven by cultural, historical, and resource-related factors, no prior review has tried to estimate the prevalence and influencing factors of T&CM use and disclosure among cancer patients in this region. This study aims to examine the prevalence and disclosure rates of T&CM use among cancer patients in Asia to assess various factors influencing its use across different cancer treatment settings in Asia. Systematic research on T&CM use was conducted using four databases (PubMed, EMBASE, Web of Science, and CINAHAL) from inception to January 2023. Quality was assessed using the Appraisal Tool for Cross-Sectional Studies (AXIS). A random effects model was used to estimate the pooled prevalence of T&CM use, and data analysis was performed using Stata Version 16.0. Among the 4849 records retrieved, 41 eligible studies conducted in 14 Asian countries were included, involving a total of 14,976 participants. The pooled prevalence of T&CM use was 49.3%, ranging from 24.0% to 94.8%, and the disclosure rate of T&CM use was 38.2% (11.9% to 82.5%). The most commonly used T&CM modalities were herbal medicines and traditional medicine. Females were 22.0% more likely to use T&CM than males. A subgroup analysis revealed the highest prevalence of T&CM use was found in studies conducted in East Asia (62.4%) and those covered by both national and private insurance (55.8%). The disclosure rate of T&CM use to physicians remains low. Moreover, the factors influencing this disclosure are still insufficiently explored. Since the disclosure of T&CM use is a crucial indicator of patient safety and the quality of cancer treatment prognosis, future research should focus on identifying the determinants of non-disclosure.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Global Health and Development, Graduate School, Hanyang University, Seoul 04763, Republic of Korea.
- Institute of Health Services Management, Hanyang University, Seoul 04763, Republic of Korea.
- Department of Preventive Medicine, College of Medicine, Hanyang University, Seoul 04763, Republic of Korea.
- Department of Obstetrics and Gynecology, College of Medicine, Hanyang University, Seoul 04763, Republic of Korea.
- School of Public Health, Dow University of Health Sciences, Karachi 75330, Pakistan.
ORCID-Profile: Soojeung Choi, Dain Choi, Dongwoon Han
Zitieren
APA
Choi, S., Karki Kunwor, S., Im, H., Choi, D., Hwang, J., Ahmed, M., & Han, D. (2024). Traditional and Complementary Medicine Use among Cancer Patients in Asian Countries: A Systematic Review and Meta-Analysis. Cancers, 16(18), 3130. https://doi.org/10.3390/cancers16183130
Vancouver
Choi S, Karki Kunwor S, Im H, Choi D, Hwang J, Ahmed M, et al. Traditional and Complementary Medicine Use among Cancer Patients in Asian Countries: A Systematic Review and Meta-Analysis. Cancers. 2024;16(18):3130. doi:10.3390/cancers16183130
BibTeX
@article{Choi2024,
author = {Choi, Soojeung and Karki Kunwor, Sangita and Im, Hyeabin and Choi, Dain and Hwang, Junghye and Ahmed, Mansoor and Han, Dongwoon},
title = {Traditional and Complementary Medicine Use among Cancer Patients in Asian Countries: A Systematic Review and Meta-Analysis},
journal = {Cancers},
year = {2024},
volume = {16},
number = {18},
pages = {3130},
doi = {10.3390/cancers16183130}
}
EUVIMED